These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34333739)

  • 1. Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda.
    Nakasujja N; Vecchio AC; Saylor D; Lofgren S; Nakigozi G; Boulware DR; Kisakye A; Batte J; Mayanja R; Anok A; Reynolds SJ; Quinn TC; Pardo CA; Kumar A; Gray RH; Wawer MJ; Sacktor N; Rubin LH
    J Neurovirol; 2021 Aug; 27(4):519-530. PubMed ID: 34333739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.
    Rubin LH; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Kisakye A; Batte J; Mayanja R; Anok A; Lofgren SM; Boulware DR; Dastgheyb R; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N
    J Neurovirol; 2019 Dec; 25(6):800-813. PubMed ID: 31218522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda.
    Velloza J; Celum C; Haberer JE; Ngure K; Irungu E; Mugo N; Baeten JM; Heffron R;
    AIDS Behav; 2017 Aug; 21(8):2509-2518. PubMed ID: 28634661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
    Vecchio A; Robertson K; Saylor D; Nakigozi G; Nakasujja N; Kisakye A; Batte J; Mayanja R; Anok A; Reynolds SJ; Quinn TC; Gray R; Wawer MJ; Sacktor N; Rubin LH
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):534-542. PubMed ID: 32692113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Antiretroviral Drugs on Depressive Symptomatology in Homogenous Subgroups of Women with HIV.
    Williams DW; Li Y; Dastgheyb R; Fitzgerald KC; Maki PM; Spence AB; Gustafson DR; Milam J; Sharma A; Adimora AA; Ofotokun I; Fischl MA; Konkle-Parker D; Weber KM; Xu Y; Rubin LH
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):181-194. PubMed ID: 31933016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive Symptoms Before and After Antiretroviral Therapy Initiation Among Older-Aged Individuals in Rural Uganda.
    Manne-Goehler J; Kakuhikire B; Abaasabyoona S; Bärnighausen TW; Okello S; Tsai AC; Siedner MJ
    AIDS Behav; 2019 Mar; 23(3):564-571. PubMed ID: 30229388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda.
    Saylor D; Kumar A; Nakigozi G; Anok A; Batte J; Kisakye A; Mayanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Pardo CA; Sacktor N
    J Neurovirol; 2019 Dec; 25(6):735-740. PubMed ID: 31165368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation.
    Chan BT; Weiser SD; Boum Y; Haberer JE; Kembabazi A; Hunt PW; Martin JN; Mocello AR; Bangsberg DR; Tsai AC
    AIDS Behav; 2015 Jan; 19(1):19-26. PubMed ID: 24788780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda.
    Wagner GJ; Ghosh-Dastidar B; Garnett J; Kityo C; Mugyenyi P
    Psychosom Med; 2012; 74(9):883-90. PubMed ID: 22923701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.
    Springer SA; Chen S; Altice F
    AIDS Care; 2009 Aug; 21(8):976-83. PubMed ID: 20024753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.
    Wakeham K; Harding R; Levin J; Parkes-Ratanshi R; Kamali A; Lalloo DG
    BMC Palliat Care; 2017 Jul; 17(1):8. PubMed ID: 28705181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and CD4 cell count among persons with HIV infection in Uganda.
    Kaharuza FM; Bunnell R; Moss S; Purcell DW; Bikaako-Kajura W; Wamai N; Downing R; Solberg P; Coutinho A; Mermin J
    AIDS Behav; 2006 Jul; 10(4 Suppl):S105-11. PubMed ID: 16802195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.
    Sacktor N; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Grabowski MK; Kisakye A; Batte J; Mayanja R; Anok A; Gray RH; Wawer MJ
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):216-223. PubMed ID: 30865184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and hypertension in people with HIV on long-term antiretroviral therapy in Uganda.
    Batte C; Semulimi AW; Mukisa J; Nakabuye M; Nidoi J; Mukunya D; Ratanshi RP; Castelnuovo B; Lamorde M; Meya D; Checkley W; Kalyesubula R; Siddharthan T; Babigumira JB
    PLoS One; 2024; 19(8):e0306928. PubMed ID: 39116145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual relationship power and depression among HIV-infected women in Rural Uganda.
    Hatcher AM; Tsai AC; Kumbakumba E; Dworkin SL; Hunt PW; Martin JN; Clark G; Bangsberg DR; Weiser SD
    PLoS One; 2012; 7(12):e49821. PubMed ID: 23300519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies.
    Chang JL; Lee SA; Tsai AC; Musinguzi N; Muzoora C; Bwana B; Boum Y; Haberer JE; Hunt PW; Martin J; Bangsberg DR; Kroetz DL; Siedner MJ
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):982-992. PubMed ID: 29973058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
    Bourgi K; Jenkins CA; Rebeiro PF; Palella F; Moore RD; Altoff KN; Gill J; Rabkin CS; Gange SJ; Horberg MA; Margolick J; Li J; Wong C; Willig A; Lima VD; Crane H; Thorne J; Silverberg M; Kirk G; Mathews WC; Sterling TR; Lake J; Koethe JR;
    J Int AIDS Soc; 2020 Apr; 23(4):e25484. PubMed ID: 32294337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
    Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific associations between cerebrospinal fluid inflammatory marker levels and cognitive function in antiretroviral treated people living with HIV in rural Uganda.
    Vecchio AC; Williams DW; Xu Y; Yu D; Saylor D; Lofgren S; O'Toole R; Boulware DR; Nakasujja N; Nakigozi G; Kisakye A; Batte J; Mayanja R; Anok A; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N; Rubin LH
    Brain Behav Immun; 2021 Mar; 93():111-118. PubMed ID: 33359628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral Therapy Availability and HIV Disclosure to Spouse in Rakai, Uganda: A Longitudinal Population-Based Study.
    Haberlen SA; Nakigozi G; Gray RH; Brahmbhatt H; Ssekasanvu J; Serwadda D; Nalugoda F; Kagaayi J; Wawer MJ
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):241-7. PubMed ID: 26009833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.